|
|
Volumn 30, Issue 2-3, 2004, Pages 119-154
|
|
Equal treatment for regulatory science: Extending the controls governing the quality of public research to private research
a b |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PAROXETINE;
CLINICAL TRIAL;
DATA ANALYSIS;
DRUG RESEARCH;
ENVIRONMENTAL MANAGEMENT;
ENVIRONMENTAL PLANNING;
ENVIRONMENTAL PROTECTION;
FORGERY;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HEALTH HAZARD;
HUMAN;
LAW;
MEDICAL RESEARCH;
MEDICOLEGAL ASPECT;
PROFESSIONAL MISCONDUCT;
PUBLIC HEALTH;
QUALITY CONTROL;
REVIEW;
RISK ASSESSMENT;
SCIENCE;
SELF REPORT;
STANDARDIZATION;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CONSUMER;
ETHICS;
GOVERNMENT;
GOVERNMENT REGULATION;
LEGAL APPROACH;
LEGAL ASPECT;
MANAGEMENT;
ORGANIZATION AND MANAGEMENT;
POLITICS;
RESEARCH;
SCIENTIFIC MISCONDUCT;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
LEGAL APPROACH;
CONSUMER PARTICIPATION;
GOVERNMENT REGULATION;
HUMANS;
POLICY MAKING;
POLITICS;
PRIVATE SECTOR;
PUBLIC SECTOR;
RESEARCH;
SCIENTIFIC MISCONDUCT;
UNITED STATES;
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;
|
|
EID: 5444224973
PISSN: 00988588
EISSN: None
Source Type: Journal
DOI: 10.1177/009885880403000202 Document Type: Review |
|
Times cited : (30)
|
|
References (0)
|